FDA Investigator Kine Thomas Cruse
Kine Thomas Cruse has inspections in 2 countries as of 27 Nov 2020. Kine Thomas Cruse has collaborated with a combined 524 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
27 Nov 2020
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Croatia
Co-Investigator(s):
Barbara J Rincon,
Barbara Jwilimczyk Macri,
Binh T Nguyen,
Caryn M Mcnab,
Chelsea N Sealey,
Daniel W Cline,
Dr. Chunchang Fang,
Himanshu Gupta, PhD,
James C Maclaughlin,
Jennifer M Gogley,
Jose Alopez Rubet,
Kim Lthomas Cruse,
Kristy A Zielny,
Liming Zhang,
Michael S Araneta,
Miguel A Martinez,
Minh D Phan,
Mra Greenc,
Parul M Patel,
Patrick C Klotzbuecher,
Sangeeta M Khurana, PhD,
Stephanie Mangigian, MS/OSH, RN,
Terri L Dodds,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Virgilio F Pacio, CSO,
Viviana Matta
Kine Thomas Cruse's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2002 | EIR | Pliva Hrvatska d.o.o. - EIR, 2002-09-13 |
August, 2002 | FDA 483 Response | Pliva Hrvatska d.o.o. - Form 483R, 2002-08-30 |
August, 2002 | FDA 483 | Pliva Hrvatska d.o.o. - Form 483, 2002-08-30 |
June, 2002 | EIR | Irvine Pharmaceutical Services, Inc. - EIR, 2002-06-13 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more